Ilex Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$80.3M Buy
941,604
+350,041
+59% +$31.7M 1.56% 23
2026
Q2
$54.2M Buy
+591,563
New +$51.8M 1.11% 32
2026
Q1
– Sell
-2,087,190
Closed -$165M – 79
2025
Q4
$165M Buy
+2,087,190
New +$164M 4.65% 5
2025
Q3
– Sell
-686,136
Closed -$62.4M – 149
2025
Q2
$62.4M Buy
+686,136
New +$62.6M 2.06% 15
2025
Q1
– Sell
-689,065
Closed -$62.6M – 192
2024
Q4
$62.6M Buy
+689,065
New +$65.8M 4.01% 8
2024
Q3
– Sell
-473,410
Closed -$45.9M – 26
2024
Q2
$45.9M Buy
+473,410
New +$43.7M 4.71% 11
2024
Q1
– Sell
-1,488,356
Closed -$119M – 21
2023
Q4
$119M Buy
+1,488,356
New +$112M 16.57% 1

Other funds holding CL

Ilex Capital Partners's CL Position: Q3 2026 in Review

Ilex Capital Partners increased its Colgate-Palmolive (CL) stake by 59% in Q3 2026, buying an estimated $31.7M and bringing the position to 941,604 shares worth $80.3M. The position accounts for 1.56% of the portfolio, ranked #23.

Ilex Capital Partners first reported a position in CL in Q4 2023 and has held it in 7 quarters since. The position peaked at $165M in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Ilex Capital Partners held 941,604 shares of Colgate-Palmolive worth $80.3M as of Q3 2026.
  • Ilex Capital Partners bought 350,041 Colgate-Palmolive shares in Q3 2026, an estimated $31.7M.
  • Colgate-Palmolive made up 1.56% of Ilex Capital Partners's portfolio in Q3 2026, its #23 holding.
  • Ilex Capital Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 7 quarters since.
  • Ilex Capital Partners's Colgate-Palmolive position peaked at $165M in Q4 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Ilex Capital Partners's 13F filing for Q3 2026, filed 13 Nov 2026.